Infusion of BCR/Abl Peptide-Reactive Donor T Cells to Achieve Molecular Remission of Chronic Myeloid Leukemia After CD34+ Selected Allogeneic Hematopoietic Cell Transplantation
Leukemia - United Kingdom
doi 10.1038/sj.leu.2404383
Full Text
Open PDFAbstract
Available in full text
Date
August 31, 2006
Authors
Publisher
Springer Science and Business Media LLC